Key result
The MitraClip procedure significantly reduced mitral regurgitation to ≤2+ at 30 days in 76.8% of patients compared to 0% at baseline (p<0.001).
Why the study?
Does percutaneous mitral valve repair with the MitraClip reduce mitral regurgitation in patients from the Asia-Pacific region?
Observational (n=142)
Yes
Does percutaneous mitral valve repair with the MitraClip reduce mitral regurgitation in patients from the Asia-Pacific region?
Absolute Event Rate: 76.8% vs 0%
p-value: p=<0.001
Percutaneous mitral valve repair with the MitraClip demonstrates high acute procedural success and significant reduction in mitral regurgitation at 30 days in an Asia-Pacific cohort.
No takes yet. Share an insight, caveat, or question.
Extends MitraClip evidence to Asia-Pacific patients; leaves open randomized confirmation before practice change.
Yeo et al. (2014) conducted an observational in Mitral regurgitation (n=142). MitraClip procedure vs. Baseline was evaluated on Reduction in MR to ≤2+ at 30 days (p=<0.001). The MitraClip procedure significantly reduced mitral regurgitation to ≤2+ at 30 days in 76.8% of patients compared to 0% at baseline (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: